Same Indication

Nivolumab vs Vancomycin

Nivolumab vs Vancomycin: Overview

This comparison examines the pharmacological differences between Nivolumab and Vancomycin.

Mechanism of Action

Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

Vancomycin: Glycopeptide antibiotic inhibiting cell wall synthesis by binding D-Ala-D-Ala terminus of peptidoglycan precursors.

Pharmacokinetics

Half-life: Nivolumab β€” 27 days; Vancomycin β€” 4-6 hours.

Chemical Properties

Molecular Formula: Vancomycin β€” C66H75Cl2N9O24.

Molecular Weight: Vancomycin β€” 1449.2500 g/mol.

Type: Nivolumab β€” Antibody; Vancomycin β€” Small molecule.